NUVB
Nuvation Bio Inc - Ordinary Shares - Class A

2,566
Loading...
Loading...
Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
220

Frequently Asked Questions

What is Market Cap of Nuvation Bio Inc - Ordinary Shares - Class A?
What is the 52-week high for Nuvation Bio Inc - Ordinary Shares - Class A?
What is the 52-week low for Nuvation Bio Inc - Ordinary Shares - Class A?
What is Nuvation Bio Inc - Ordinary Shares - Class A stock price today?
What was Nuvation Bio Inc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Nuvation Bio Inc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Nuvation Bio Inc - Ordinary Shares - Class A?
What is the 50-day moving average of Nuvation Bio Inc - Ordinary Shares - Class A?
How many employess does Nuvation Bio Inc - Ordinary Shares - Class A has?

Latest NUVB News

View

Advertisement. Remove ads.

Advertisement. Remove ads.